Dr. Martens Plc (3U2) AI Stock Analysis
Dr. Martens Plc
(Frankfurt:3U2)
No summary available
Dr. Martens Plc (3U2) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 627.90M
- Dividend Yield
- 3.84%
- Average Volume (3M)
- 1,443
- Price to Earnings (P/E)
- 26.3
- Beta (1Y)
- 0.95
- Revenue Growth
- -5.76%
- EPS Growth
- 360.66%
- Country
- Germany
- Employees
- 2,377
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Apparel - Footwear & Accessories
Dr. Martens Plc Business Overview & Revenue Model
Company Description
Dr. Martens plc is a global footwear enterprise that handles the entire process of conceiving, crafting, sourcing materials for, marketing, selling, and distributing its products. The company boasts a significant international presence, serving custo...
Dr. Martens Plc Earnings Call Summary
The earnings call presented a mix of positive and negative aspects. There was notable improvement in revenue quality, operating profit, and debt reduction. Growth was observed in the Americas and APAC regions, along with an increase in full-price sales. However, challenges in the EMEA market, particularly in direct-to-consumer revenue, and ongoing issues with boots and sandals, along with tariff headwinds, were highlighted as areas of concern.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
During the call, the company provided guidance indicating strong performance in key metrics and adherence to their strategic plan. They reported a year-on-year revenue increase of GBP 2.7 million, reaching GBP 327.3 million, with a focus on improving revenue quality through full-price sales. Operating profit improved by GBP 6.5 million, shifting from a loss last year to a GBP 3.4 million profit. However, the profit before tax remains a loss, albeit significantly improved from the previous year. The company's dividend was declared at 0.85p, and net bank debt decreased by GBP 33 million to GBP 154 million. The strategy included focusing on reducing markdowns, expanding product offerings, and leveraging partnerships in new markets. The company also emphasized cost control, with a net debt-to-EBITDA ratio finishing at 2.1x, and aimed for sustainable growth in FY '27 and beyond.
Dr. Martens Plc Peers Comparison
Overall Rating
GB:NXT80Outperform
GB:JD67Neutral
GB:SHOE53Neutral
GB:ASC52.9Neutral
GB:BRBY50Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:NXT | 80Outperform | GBP 17.53B | 19.19 | 58.63% | 4.09% | 12.52% | 19.24% |
| GB:JD | 67Neutral | GBP 4.33B | 8.04 | 18.67% | 1.38% | 2.06% | 14.07% |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
| GB:SHOE | 53Neutral | GBP 30.40M | -33.25 | -3.48% | ― | -10.10% | -145.45% |
| GB:ASC | 53Neutral | GBP 514.49M | -2.22 | -155.17% | ― | -15.00% | 21.71% |
| GB:BRBY | 50Neutral | GBP 3.80B | 183.45 | 2.29% | ― | -1.67% | ― |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:3U2 | Dr. Martens Plc | 0.76 | -0.21 | -21.84% | |
| GB:ASC | ASOS plc | 430.00 | 194.50 | 82.59% | |
| GB:BRBY | Burberry Group plc | 1053.00 | -162.00 | -13.33% | |
| GB:NXT | Next Plc | 15355.00 | 1669.57 | 12.20% | |
| GB:SHOE | Shoe Zone | 67.50 | -14.00 | -17.18% | |
| GB:JD | JD Sports Fashion | 91.94 | 3.18 | 3.58% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.